Structures of glycinamide ribonucleotide transformylase (PurN) from Mycobacterium tuberculosis reveal a novel dimer with relevance to drug discovery.
Zhang, Z., Caradoc-Davies, T.T., Dickson, J.M., Baker, E.N., Squire, C.J.(2009) J Mol Biol 389: 722-733
- PubMed: 19394344 
- DOI: 10.1016/j.jmb.2009.04.044
- Primary Citation of Related Structures:  
3DA8, 3DCJ - PubMed Abstract: 
Enzymes from the de novo purine biosynthetic pathway have been exploited for the development of anti-cancer drugs, and represent novel targets for anti-bacterial drug development. In Mycobacterium tuberculosis, the cause of tuberculosis, this pathway has been identified as essential for growth and survival ...